BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35135476)

  • 1. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq.
    Li W; Li X; Ma X; Xiao W; Zhang J
    BMC Genomics; 2022 Feb; 23(1):105. PubMed ID: 35135476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
    Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
    Front Genet; 2022; 13():903117. PubMed ID: 35692827
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
    Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
    J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma.
    Liu T; Wang Y; Li Z; Sun L; Yang K; Chen J; Han X; Qi L; Zhou X; Wang P
    Heliyon; 2023 Nov; 9(11):e21285. PubMed ID: 38027812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis.
    Liu HT; Rau CS; Liu YW; Hsieh TM; Huang CY; Chien PC; Lin HP; Wu CJ; Chuang PC; Hsieh CH
    J Hepatocell Carcinoma; 2023; 10():2383-2395. PubMed ID: 38164510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
    Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
    BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
    Front Immunol; 2022; 13():918140. PubMed ID: 35833147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients.
    Liu J; Dou M; Liu X; Lu Y; Lu W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11995-12012. PubMed ID: 37421455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases.
    Zhou W; Wang C; Chang J; Huang Y; Xue Q; Miao C; Wu P
    Front Pharmacol; 2021; 12():722728. PubMed ID: 34489709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
    Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L
    Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of RNA methylation in gastrointestinal cancers.
    Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
    Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain.
    Amort T; Rieder D; Wille A; Khokhlova-Cubberley D; Riml C; Trixl L; Jia XY; Micura R; Lusser A
    Genome Biol; 2017 Jan; 18(1):1. PubMed ID: 28077169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The abdominal aortic aneurysm-related disease model based on machine learning predicts immunity and m1A/m5C/m6A/m7G epigenetic regulation.
    Tian Y; Fu S; Zhang N; Zhang H; Li L
    Front Genet; 2023; 14():1131957. PubMed ID: 36911406
    [No Abstract]   [Full Text] [Related]  

  • 14. Insights into the regulatory role of RNA methylation modifications in glioma.
    Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
    J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of RNA modification in hepatocellular carcinoma.
    Feng Q; Wang D; Xue T; Lin C; Gao Y; Sun L; Jin Y; Liu D
    Front Pharmacol; 2022; 13():984453. PubMed ID: 36120301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decomposition of RNA methylome reveals co-methylation patterns induced by latent enzymatic regulators of the epitranscriptome.
    Liu L; Zhang SW; Zhang YC; Liu H; Zhang L; Chen R; Huang Y; Meng J
    Mol Biosyst; 2015 Jan; 11(1):262-74. PubMed ID: 25370990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine.
    Xu Y; Zhang M; Zhang Q; Yu X; Sun Z; He Y; Guo W
    Front Cell Dev Biol; 2021; 9():767668. PubMed ID: 34917614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.
    Zhou W; Wang X; Chang J; Cheng C; Miao C
    Crit Rev Clin Lab Sci; 2022 May; 59(3):203-218. PubMed ID: 34775884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCB126 Exposure Revealed Alterations in m6A RNA Modifications in Transcripts Associated With AHR Activation.
    Aluru N; Karchner SI
    Toxicol Sci; 2021 Jan; 179(1):84-94. PubMed ID: 33064826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis.
    Chen K; Song B; Tang Y; Wei Z; Xu Q; Su J; de Magalhães JP; Rigden DJ; Meng J
    Nucleic Acids Res; 2021 Jan; 49(D1):D1396-D1404. PubMed ID: 33010174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.